Bristol Myers Squibb, by way of its RayzeBio unit, has taken a big step in furthering its commitment to radiopharmaceuticals, ...

Frontier Large Language Models have improved. More data became accessible. Neither solved the hardest questions. Here's what ...

On Wednesday, the U.S. Court of Appeals for the Fifth Circuit affirmed (PDF) a previous ruling in district court rebuffing ...

RevMed’s leadership, too, highlighted the significance of Rasonque’s approval in a call with investors yesterday.

Amgen and AstraZeneca’s inflammatory disease drug Tezspire has clinched a phase 3 win in eosinophilic esophagitis (EoE) as ...

Artis BioSolutions opened the doors to a new manufacturing center in Bilbao, Spain, that expands the CDMO’s production ...

The Trump administration looks set to unveil a new slate of most favored nation (MFN) drug pricing deals with several ...

It’s back-to-school season, and several students are heading to the classroom with a little extra help on the financial side thanks to immunology drugmaker AbbVie.  | Since its immunology scholarship ...

Less than a month after initiating a drug recall after cardboard was fou | Baxter has initiated a recall of two products ...

Following dynamite data that earned a standing ovation at the American Society of Clinical Oncology in June, Revolution ...

Fresh off a phase 3 win in biliary tract cancer, Akeso CEO Michelle Xia, Ph.D., is touting the PD-1xVEGF bispecific antibody ...

McKesson Corporation is expanding its drug development and commercialization capacity to the tune of $2.25 billion. | The ...